UBS Group set a €23.00 ($26.74) price target on Evonik Industries (FRA:EVK) in a research report released on Thursday morning, Borsen Zeitung reports. The firm currently has a sell rating on the stock.
Several other equities analysts have also weighed in on the stock. Morgan Stanley set a $165.00 price objective on shares of Caterpillar and gave the company a buy rating in a research report on Wednesday, April 10th. Sanford C. Bernstein set a €68.00 ($79.07) price objective on shares of Basf and gave the company a neutral rating in a research report on Tuesday, June 25th. Goldman Sachs Group reaffirmed a hold rating and set a $8.40 price objective on shares of Deutsche Bank in a research note on Monday, July 8th. Independent Research set a €215.00 ($250.00) price objective on shares of Munchener Ruckvers and gave the company a neutral rating in a research note on Wednesday, May 8th. Finally, Credit Suisse Group reaffirmed a hold rating on shares of Imperial Oil in a research note on Friday, April 12th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and ten have assigned a buy rating to the stock. Evonik Industries presently has a consensus rating of Hold and a consensus target price of €30.90 ($35.93).
FRA:EVK opened at €25.32 ($29.44) on Thursday. Evonik Industries has a twelve month low of €26.78 ($31.14) and a twelve month high of €32.97 ($38.34). The firm’s 50-day simple moving average is €24.82.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Recommended Story: Hold Rating
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.